Table 1 Univariable and multivariable analysis of overall survival according to HOXA13 or HOXA11-13 expression and select variables.

From: 3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia

 

Univariate

Multivariate (HOXA13)

Multivariate (HOXA11-13)

HR

95% CI

P value

HR

95% CI

P value

HR

95% CI

P value

HOXA13 expression (FPKM)

≥1 vs. <1

4.675

1.39–15.69

0.013

38.25

1.37–1071

0.032

   

HOXA11-13 expression (FPKM)

≥1 vs. <1

5.872

1.84–18.74

0.003

   

8.84

0.82–95.24

0.072

Gender

Males vs. female

1.13

0.42–3.01

0.806

0.959

0.05–17.78

0.978

0.89

0.066–12.015

0.93

Age

Pediatric vs. adult

0.21

0.07–0.64

0.006

0.154

0.006–3.684

0.248

0.34

0.014–8.444

0.512

WBC

Low vs. high

1.46

0.62–3.43

0.381

73.52

1.59–3390

0.028

31.95

1.5–680.5

0.0264

Hemoglobin

1

0.99–1.02

0.571

1.02

0.94–1.11

0.574

1.008

0.94–1.077

0.813

Platelet

1

0.99–1

0.952

0.986

0.968–1.004

0.127

0.987

0.971–1.004

0.139

Hepatosplenomegaly

Yes vs. no

1.47

0.34–6.33

0.605

0.24

0.004–15.882

0.504

1.67

0.022–128.414

0.817

Blasts in BM

1.01

0.98–1.03

0.621

1.107

0.906–1.352

0.319

1.08

0.9–1.294

0.407

  1. WBC white blood cell count, HR hazard ratio, CI confidence interval.